PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,720 Cr | ₹4,559 Cr | ₹5,505 Cr | ₹4,023 Cr | ₹2,910 Cr |
What is the latest Total Debt ratio of PIRAMAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹4,720 Cr |
| Mar2024 | ₹4,559 Cr |
| Mar2023 | ₹5,505 Cr |
| Mar2022 | ₹4,023 Cr |
| Mar2021 | ₹2,910 Cr |
How is Total Debt of PIRAMAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,720 Cr | 3.54 | |
| Mar2024 | ₹4,559 Cr | -17.18 | |
| Mar2023 | ₹5,505 Cr | 36.82 | |
| Mar2022 | ₹4,023 Cr | 38.25 | |
| Mar2021 | ₹2,910 Cr | - | |
Compare Total Debt of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,742.6 Cr | -0.4% | -9.8% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.4% |
-9.8% |
-36.1% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses